Sensei Pharmaceuticals, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Gaithersburg MD United States (1999)

Organization Overview

First Clinical Trial
2016
NCT03120832
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Sensei Biotherapeutics | Sensei Biotherapeutics, Inc.